Product image of Nebitrix (Nebivolol Hydrochloride) supplied by GNH India

Nebitrix

Active Ingredient:
Nebivolol Hydrochloride
Origin:
EU

Nebitrix (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebitrix, is a beta blocker presented as an oral tablet for oral use. It selectively blocks β1‑adrenergic receptors and also enhances nitric oxide release, helping to lower blood pressure and improve cardiac function in adults with hypertension or heart failure.

GNH India supplies Nebitrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory‑approved batches for global distribution.

Manufacturer / TM Owner

Glenmark Pharmaceuticals S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nebitrix is a selective β1‑adrenergic receptor antagonist used in the management of cardiovascular conditions.

  • Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.
  • Heart failure: improves left ventricular ejection fraction and reduces hospitalization risk in chronic heart failure.
  • Elderly patients with hypertension: provides effective blood pressure control with a favorable tolerability profile.

How It Works

  • Nebivolol acts as a highly selective β1‑adrenergic receptor antagonist, reducing heart rate and myocardial contractility while sparing β2 receptors. In addition, it stimulates endothelial nitric oxide synthase, increasing nitric oxide release and causing vasodilation. The combined beta‑blockade and nitric oxide‑mediated vasodilation result in lowered systemic vascular resistance and blood pressure, improving cardiac efficiency in hypertensive and heart‑failure patients.

Side Effects

Nebitrix may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Headache
  • Dizziness
  • Fatigue
  • Nausea
  • Bradycardia
  • Peripheral edema

Serious or Rare Side Effects

  • Severe bradycardia
  • Atrioventricular block
  • Bronchospasm
  • Allergic reactions (rash, angioedema)
  • Liver enzyme elevation
  • Worsening heart failure

Precautions & Warnings

When prescribing Nebitrix, clinicians should consider several precautionary measures to ensure safe use.

  • Blood pressure monitoring: check baseline and periodic readings.
  • Heart rate assessment: observe for bradycardia before and during therapy.
  • Asthma or COPD: use with caution due to potential bronchoconstriction.
  • Concomitant beta‑blockers: avoid additive effects that may cause excessive slowing.
  • Renal impairment: adjust dose in patients with severe renal dysfunction.
  • Store at room temperature: keep in the original pack, protect from moisture and heat.

Avoid Interactions

Nebitrix can interact with other medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid)

  • Other beta‑blockers: additive negative chronotropic effects.
  • Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem): increased risk of AV block.
  • Potent CYP2D6 inhibitors (paroxetine, fluoxetine): may raise nebivolol plasma levels.
  • Severe bradycardic agents (digoxin): heightened risk of bradycardia.
  • High‑dose ACE inhibitors combined with nebivolol: potential excessive hypotension.

Moderate Interactions (Monitor Closely)

  • Diuretics: monitor electrolytes and blood pressure.
  • ACE inhibitors/ARBs: watch for additive hypotensive effect.
  • NSAIDs: may reduce antihypertensive efficacy.
  • Antidiabetic drugs: monitor glucose control as blood pressure changes can affect glycemia.
  • Antihistamines: observe for increased sedation or dizziness.

Frequently Asked Questions

Nebitrix, containing nebivolol, is prescribed for the management of primary hypertension and for chronic heart failure in adult patients. It helps lower elevated blood pressure and improves cardiac output by reducing heart rate and promoting vasodilation.

Nebivolol selectively blocks β1‑adrenergic receptors, decreasing heart rate and contractility. At the same time it stimulates nitric oxide release from the endothelium, causing blood vessels to relax. The combination of reduced cardiac output and vasodilation leads to lower systemic blood pressure.

The specific dose of Nebitrix is determined by the prescribing clinician based on the patient’s medical condition, age, renal function and response to therapy. Dosage adjustments are made according to clinical guidelines and individual patient needs.

Safety data for nebivolol in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nebivolol is a highly β1‑selective blocker with additional nitric‑oxide‑mediated vasodilatory properties, which can offer better tolerability and fewer metabolic side effects compared with non‑selective beta blockers. Its unique profile may be advantageous in patients who experience fatigue or cold extremities on other agents.

Nebitrix should be stored at room temperature, below 25 °C, in the original packaging. Protect the tablets from moisture, direct sunlight and excessive heat to maintain product stability.

Nebitrix is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include severe bradycardia, atrioventricular block, bronchospasm in patients with reactive airway disease, and rare cases of liver enzyme elevation. Patients should be monitored for signs of these reactions, especially during treatment initiation or dose changes.

Nebitrix should be avoided in patients with known hypersensitivity to nebivolol, those with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, uncontrolled asthma or COPD, and in individuals taking contraindicated medications such as other beta blockers without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nebivolol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT